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The persistent inﬂammatory state is common in diabetes and chronic kidney disease (CKD). These patients present exercise
intolerance and increased arterial stiﬀness. Long-term aerobic exercise has been associated with better arterial compliance,
antidiabetic and antiinﬂammatory beneﬁts. We assessed the hypothesis that in patients with diabetes and CKD, better aerobic
capacity is associated with less inﬂammatory state and arterial stiﬀness. Thirty-nine CKD patients (17 in hemodialysis) were
evaluated. According to CKD etiology two patient groups were obtained: group of diabetics (GD) was formed by 11 patients and
nondiabetics (GND) formed by 28 patients. Central blood pressure and arterial stiﬀness were evaluated by Sphygmocor device.
Carotida intima-media thickness (CA-IMT) was evaluated by ultrasonography. Aerobic capacity was measured by estimated
VO2max according to treadmill test by Bruce protocol. The GD showed a higher frequency of C-reactive protein above laboratory
cutoﬀ (P = 0.044), higher frequency of male gender, and a non signiﬁcant higher value of VO2max (P = 0.099). The CA-IMT was
similar. Only better aerobic capacity was associated with lower frequency of high C-reactive protein when adjusted to diabetes and
gender in a logistic regression model. In conclusion, aerobic capacity was associated with inﬂammatory state, in CKD patients,
independently of diabetes presence.
1.Introduction
Chronic kidney disease (CKD), characterized by irreversible
loss of renal function [1], is a major public health problem
in the world. The prevalence of CKD increases with age
and reaches around 17% of individuals over 60 years [2].
Cardiovascular (CV) disease is the leader cause of morbidity
and mortality in these patients.
One of the major risk factors for development of CKD is
diabetes, which causes, in addition to kidney damage, several
cardiovascular comorbidities and visual and peripheral vas-
cular complications. Persistent chronic microinﬂammatory
state is very common in diabetic and CKD patients. It is
associated with malnutrition and cardiovascular disease and
is a potent predictor of mortality [3].
Increased arterial stiﬀness has been recognized as impor-
tant predictors of CV diseases in patients with CKD and
diabetes patients and is associated with chronic inﬂamma-
tory state [4]. Like pulse wave velocity (PWV), central blood
pressure (CBP), and augmentation index (AIx), carotid
intima-media wall thickness (CA-IMT) is also a predictor of
CV mortality in elderly patients with ischemic heart disease,
hypertension, diabetes, and CKD [5].
CKD patients usually manifest symptoms of exercise
intolerance such as muscle weakness and fatigue and are
less active, exhibiting muscle atrophy even when compared2 Experimental Diabetes Research
t oi n a c t i v en o r m a ls u b j e c t s[ 6]. CKD patients substantially
improve their strength, power, and muscle endurance,
evaluated by exercise capacity and physical function tests
aftertraining[7].Othershavereportedthattrainingimprove
quality of life, maximum oxygen uptake (VO2max), muscle
gain in mass and capillary density, velocity of nerve conduc-
tion, and blood pressure (BP) [8–11].
Recent evidence had shown that physical activity can
ameliorate inﬂammatory state in CKD [12]. Two interven-
tional studies showed a reduction of inﬂammatory markers
with aerobic training [13, 14]. Another two studies, one
interventional[15]andonetransversal[16]havenotdemon-
strated any eﬀect in inﬂammatory state. Thus, the beneﬁts
of physical activity and its importance were recognized in
diabetic patients from the general population, and physical
training is fully recommended [17]. However, the eﬀective-
ness of physical activity in the prevention or improvement
of inﬂammatory state in diabetic CKD patients had not yet
been proved [15].
Therefore, the aim of this study is to evaluate the asso-
ciation between aerobic capacity and presence of diabetes,
inﬂammation, arterial stiﬀness, and CA-IMT in chronic
kidney disease patients.
2.MaterialsandMethods
Were included hemodialysis patients for at least six months
orCKDpredialysispatients.Allsubjectswereagedmorethan
18 years. Subjects unable to perform exercise testing, with
coronary heart disease or previous coronary artery bypass,
active infection, cancer, or liver cirrhosis were excluded.
Informedconsentwasobtainedfromeachpatient.Thisstudy
was approved by Research Ethics Committee of the Botucatu
Medical School with the protocol 3083/2009.
Clinical data evaluated were age, gender, body mass
index, and kidney disease etiology. The following laborato-
rial data was evaluated: hemoglobin, calcium, phosphorus,
parathyroid hormone, albumin, iron, ferritin, transferrin
saturation, C-reactive protein, creatinine, and creatinine
clearance. All laboratorial evaluations were performed in the
morning while fasting. The hemodialysis patients were eval-
uated in the morning while fasting in the interdialytic day.
The C-reactive protein was evaluated by dry chemistry
(VITROS kit, Ortho-Clinical Diagnostics, Rochester, NY,
USA), and test sensitivity was 0.1mg/dL. Elevated CRP was
deﬁned when a patient had values superior to 1mg/dL, as
deﬁned by superior limit of our laboratory.
Patients who met the inclusion criteria underwent
Sphygmocor CPV (AtCor Medical, Australia) evaluation for
CBP, PWV, and AIx. The measurements were performed in
supine position. The BP stabilization was considered when
the diﬀerence between three consecutive measurements in
ﬁve-minute interval was not greater than 5mmHg. Average
and maximum of left and right CA-IMT by ultrasonography
according to Mannheim carotid intima-media consensus
[18]w e r ee v a l u a t e d .
For the estimation of VO2max, the patients were sub-
mitted to a treadmill test (Bruce protocol [19]), and the
appropriate formula for nonathletes was used to calculate
this variable as follows: VO2max = (time × 3.29) + 4.07 for
men, and VO2max= (time × 3.36) + 1.06 for women. All
evaluations were performed on the same day in the same
sequence. Hemodialysis patients underwent their examina-
tions on interdialytic days.
According to the kidney disease etiology, two patient
groups were obtained. Group D (GD) formed by diabetic
patients and group ND (GND) formed by nondiabetic
patients. The groups were compared regarding age, body
massindex,andlaboratorialdata,systolic,diastolicandpulse
CBP, PWV, Aix, and CA-IMT.
For comparison between groups, t-test or Mann-
Whitneywasusedwhenappropriate.Multiplelogisticregres-
sions were performed to identify variables independently
associated with inﬂammation and selected variables with
statistical probability of <0.1 between groups. Values were
expressed as mean ± standard deviation to parametric
variables or median (ﬁrst–third quartile) when appropriate.
A P<0.05 was considered statistically signiﬁcant.
3. Results
There were included 39 patients (17 in hemodialysis). Clin-
ical and laboratory characteristics are shown in Table 1.T h e
GD was formed by 11 diabetic patients and the GND by
28 nondiabetic patients, there were 13 (46%) patients in
hemodialysis in GND and four (36%) in GD (P = 0.725).
Other clinical and laboratorial variables of the groups are
shown in Tables 2 and 3,r e s p e c t i v e l y .T h en u m b e ro fm a l e
patients was higher in GD compared to GND, with P =
0.011.
Diabetic group had a CRP value of 1.50 (0.32–2.72)
mg/dL and GND 0.5 (0.20–0.75) mg/dL. When patients
were divided according to the inﬂammatory status (CRP >
1mg/dL or CRP ≤ 1mg/dL) a signiﬁcantly greater number
of chronic inﬂammatory state patients was found in GD
(P = 0.044; Table 3). The values of creatinine, creatinine
clearance, hemoglobin, calcium, phosphorus, parathyroid
hormone, albumin, ferritin, and transferrin saturation were
not diﬀerent between groups (Table 3).
Was observed a trend of higher VO2max values in the
patients without diabetes compared to diabetic patients
(27.9 ±8.09mL/kg/min in GND and 23.3 ±7.08mL/kg/min
in GD, P = 0.099; Table 2). Reanalyzing VO2max by gender,
that is, excluding female sex from analysis, we have VO2max
of 30.9 ± 8.58mL/kg/min in nondiabetic group (n = 9n o n -
diabetic men) and 23.5 ± 7.44mL/kg/min (P = 0.042) in
diabetic group (n = 13 diabetic men), so, reinforcing the
diﬀerence in VO2max between diabetics and nondiabetics.
Thickness of the intimae-media right carotid artery showed
a trend of higher values in diabetic patients (0.9 ± 0.29mm
in GD and 0.76 ± 0.216, P = 0.081), other indexes of
carotid thickness were similar between groups. Comparing
the values of arterial stiﬀness indexes, GD had similar values
of GND.
In multiple logistic regression, with CRP as dependent
variable (Table 4), the main determinant of C-reactiveExperimental Diabetes Research 3
Table 1: Clinical variables and laboratorial characteristics of
patients.
Patients 39
Hemodialysis 17
Predialysis 22
Age (years) 54.9 ± 14.16
Kidney disease etiology
Hypertension 16
Diabetes 11
Glomerulopathies 7
Others 5
BMI (Kg/m2)2 6 .5 ±5.25
Central SBP (mmHg) 122 ±19.3
Central DBP (mmHg) 83 ±12.8
Central PP (mmHg) 39 ±13.4
Pulse wave velocity (m/s) 8.3 ± 1.26
Augmentation index (%) 26.3 ± 14.02
VO2max (mL/kg/min) 26.6 ±8.02
CA-IMT L—m (mm) 0.79 ± 0.194
CA-IMT L—mx (mm) 0.96 ± 0.234
CA-IMT R—m (mm) 0.81 ± 0.247
CA-IMT R—mx (mm) 0.97 ± 0.273
Presence of atherosclerotic plaque (%) 41%
Creatinine (mg/dL) 6.0 ± 4.29
Clearance of creatinine (mL/min) 32 ±20.4
Hemoglobin (g/dL) 12 ±1.7
Calcium (mg/dL) 9.3 ± 0.79
Phosphorus (mg/dL) 4.8 ± 1.48
CRP (mg/dL) 0.9 ± 1.06
PTH (pg/mL) 493 ±553.3
Albumin (g/dL) 4 ±0.45
Ferritin (g/dL) 635 ±568.1
Transferrin saturation (%) 33.5 ± 15.77
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood
pressure; PP: pulse pressure; PWV: pulse wave velocity; AIx: augmentation
index; CA-IMT L—m: mean of left carotid intima-media thickness; CA-
IMT L—mx: maximal of left carotid intima-media thickness; CA-IMT R—
m:meanofrightcarotidintima-mediathickness;CA-IMTR—mx:maximal
of right carotid intima-media thickness; CRP: C-reactive protein; PTH:
parathyroid hormone.
protein was VO2max (P = 0.024). Gender and diabetes
were not independently associated with inﬂammatory state
(P = 0.210andP = 0.107,resp.).Figure 1showsthenegative
correlation between C-reactive protein and VO2max, in all
patients, where the higher the aerobic capacity, the lower
their inﬂammatory state (R =− 0.514, P<0.001).
4. Discussion
The C-reactive protein is a sensitive marker of inﬂammation,
and an increase in its levels has been associated with higher
risk of vascular disease [20]. Diabetic CKD patients’ have
high concentration of CRP, and improvement of aerobic
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Figure 1: Correlation between C-reactive protein and VO2max.
GND: nondiabetic group; GD: diabetic group.
capacity could aﬀect that variable. The main result of this
work is that CRP was not independently associated with
diabetes when we take into account the VO2 level and
that the VO2 level had a strong association with CRP
independentlyofdiabetes.Wecanspeculatethatitispossible
thattheinﬂammatorystateofchronickidneydiseasediabetic
patients would be caused, in grand part or at least in
part, by physical deconditioning. This speculative possibility
must be conﬁrmed in other studies with a great number of
individuals and especially in longitudinal and interventional
studies.
The long-term exercise training increases the nitric oxide
availabilityanddiminishestheoxidativestress,inﬂammation
and blood pressure, which improves the endothelial function
and consequently cardiovascular mortality [21–23]. Patients
with coronary artery disease submitted to adequate chronic
training with increase in the VO2max have lower levels of
CRP compared with basal values [24]. Nitric oxide, a potent
anti-inﬂammatory molecule, plays a role in this mechanism
[24].
In the elderly, training also decreased the concentration
of CRP [20, 25]. These data are consistent with our study,
since individuals with higher aerobic capacity also had a
lower inﬂammatory state. In diabetes, some recent studies
have demonstrated the role of physical training in reducing
CRP [26–29]. Experimental studies have also demonstrated
the beneﬁts of physical activity in reducing inﬂammatory
markers and oxidative stress in animals with CKD [30, 31].
According to the American College of Sports Medicine
and American Heart Association, to reduce risk of cardio-
vascular events, individuals with chronic illnesses should
performmoderate-intensityphysicalactivity,30min,5times
weekly [32].
Physical capacity proved to be an important predictor
of survival. In a study that evaluated patients with CKD
and followed them over three years, patients with a VO2max
superior to 17.5mL/kg/min had a higher survival compared
to individuals with lower peak VO2 [33]. The mean of
VO2max of the current study was 26.6 ± 8.02mL/kg/min.
Although the beneﬁts of physical training have been
demonstrated in CKD patients [11, 34–36], the results are4 Experimental Diabetes Research
Table 2: Clinical Variables between groups.
Diabetics
(n = 11)
Nondiabetics
(n = 28) P
Age (years) 60 ±13.75 3 ±13.9 0.126
Gender: male/female 10 M/1 F 13 M/15 F 0.011
BMI (Kg/m2)2 8 ±3.42 6 ±5.8 0.298
Central SBP (mmHg) 117 ±19.5 124 ±19.3 0.344
Central DBP (mmHg) 74 ±10.48 7 ±12.1 0.005
Central PP (mmHg) 43 ±15.13 7 ±12.5 0.205
PWV (m/seg) 8.3 ±1.36 8.3 ±1.24 0.884
AIx (%) 21 ±14.12 8 ±13.6 0.124
VO2max (mL/kg/min) 23.3 ±7.08 27.9 ±8.09 0.099
CA-IMT L—m (mm) 0.8 ±0.17 0.78 ±0.202 0.328
CA-IMT L—mx (mm) 1.0 ±0.20 0.94 ±0.248 0.459
CA-IMT R—m (mm) 0.9 ±0.29 0.76 ±0.216 0.081
CA-IMT R—mx (mm) 1.1 ±0.28 0.92 ±0.258 0.112
Presence of atherosclerotic
plaque (%) 54.5 35.7 0.383
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; PWV: pulse wave velocity; AIx: augmentation index;
CA-IMT L—m: mean of left carotid intima-media thickness; CA-IMT L—mx: maximal of left carotid intima-media thickness; CA-IMT R—m: mean of right
carotid intima-media thickness; CA-IMT R—mx: maximal of right carotid intima-media thickness.
Table 3: Laboratorial data.
Diabetics (n = 11) Nondiabetics
(n = 28) P
Creatinine (mg/dL) 5.8 ±4.14 6.1 ±4.42 0.863
Creatinine clearance
(mL/min) 23 ±9.63 6 ±22.8 0.206
Hemoglobin (g/dL) 11.4 ±1.51 12.3 ±1.71 0.159
Calcium (mg/dL) 8.9 ±0.69 9.4 ±0.80 0.109
Phosphorus (mg/dL) 4.9 ±1.40 4.7 ±1.52 0.633
CRP (mg/dL) 1.50 (0.32–2.72) 0.5( 0 .20–0.75) 0.021
CRP > 1.0mg/dL 6 6 0.044
CRP ≤ 1.0mg/dL 5 22
PTH (pg/mL) 454 ±473.2 509 ±591.9 0,787
Albumin (g/dL) 3.9 ±0.46 4.0 ±0.44 0.465
Ferritin (g/dL) 740 ±792.2 571 ±388.7 0.448
Transferrin saturation (%) 40 ±13.43 0 ±16.23 0.142
CRP: C-reactive protein; PTH: parathyroid hormone.
Table 4:Multiplelinearregression:C-reactiveproteinasdependent
variable.
P RR 95.0% C.I.
Lower Upper
Gender 0.210 0.221 0.021 2.335
Diabetes 0.107 7.487 0.646 86.803
VO2max
(mL/Kg/min) 0.024 0.827 0.701 0.976
controversially related to inﬂammatory markers, and few
studies have demonstrated the eﬀects of a physical activity
program on CRP in these patients. A recent pilot study of
obese diabetic CKD patients did not show any change in
CRP after a period of aerobic training [15]. In the current
study, a multiple logistic regression identiﬁed VO2max as a
principaldeterminantofC-reactiveprotein.Ourresultswere
in accordance with previous studies [37–39] and reinforce
the possibility that diabetic CKD patients would be beneﬁted
engaging in a physical activity program.
In the present study, measures of intima-media thickness
of carotid arteries and arterial stiﬀness did not correlate with
VO2max. So, better physical aerobic capacity was associated
only with the metabolic marker of inﬂammation and not
with structural or functional properties of arteries. However,
these data do not exclude that long-term assisted physicalExperimental Diabetes Research 5
training could have an impact on those parameters not
observed in this transversal study.
In the current study, some limitations must be rec-
ognized. First, a small number of subjects was evaluated,
nevertheless this number was suﬃcient to detect statistically
signiﬁcant correlations. This is a transversal study, so it
submits to limitations inherent to this design and must
be conﬁrmed in a longitudinal and interventional study.
However, we evaluated the confounding variables and took
into account those in multiple analysis. Finally, the VO2max
was indirectly measured.
In conclusion, better VO2max was associated with lower
frequencyofelevatedCRPlevelsinsubjectswithchronickid-
ney disease. The current study strengthens previous ﬁndings
and reinforces the hypothesis of cardiovascular beneﬁts with
a better aerobic capacity in CKD diabetic patients.
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